Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Featured Page 134

Featured

Featured posts

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

ME Staff - July 28, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Gold Bull

Gold Threatens to Break Resistance as Miners Soar 51% in Three...

Rafi Farber - February 8, 2016 0

Alder is a Risky Allocation in a Crowded, but Rewarding Space

- February 8, 2016 0

Phase Ib Topline Could be Make or Break for Voyager Therapeutics

ME Staff - February 5, 2016 0

Here’s Why Ariad Could Be a Top Oncology Pick for 2016

- February 4, 2016 0

Avalanche Puts Rebranding Operation in Motion with Latest Buyout

- February 3, 2016 0
biotech

Movers and Shakers: the Week so Far in Biotech

Jennifer Aldershot - February 2, 2016 0
GALT

Here are Two Companies with Upcoming Catalysts in Biotech

- February 1, 2016 0

Synergy Sets up for a Multi-billion Dollar NDA Submission

ME Staff - January 29, 2016 0
Merck & Co., Inc.

Here’s A Look at Merck’s Latest Priority Review Candidate

Roger Hannington - January 28, 2016 0

Here’s What to Look out for in Regulus’ Upcoming Interim Release

Roger Hannington - January 27, 2016 0
1...133134135...145Page 134 of 145

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 28, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 20, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 13, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019